Good Communication Key to Rheumatoid Arthritis Care (HealthDay)
Spanish ID:532958–>
Celebrex Approved To Treat Juvenile Rheumatoid Arthritis
The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use - the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older. Today’s approval follows the November 29 meeting of FDA’s Arthritis Advisory Committee, in which the committee voted 15 to 1 in favor of approval of this product.JRA is an autoimmune disease that affects approximately 30,000 to 60,000 children in the United States. [click link for full article]
